Comparative study between bisoprolol and metoprolol/hydrochlorothiazide as anti-hypertensive therapy;Estudio comparativo entre bisoprolol y metoprolol, asociados a hidroclorotiazida, como terapia antihipertensiva

Archivos del Instituto de Cardiologia de Mexico

Volumn 70, Issue 6, 2000, Pages 589-595

  Unzueta Montoya, A ^a   Unzueta A , Jr ^a   Ordonez Toquero G ^a   Villasis Keever, M A ^a   Cocoletzi Lopez J ^a   Medina Santillan R M ^a  

^a NONE   (Mexico)

Author keywords

Bisoprolol hydrochlorotiazide; Met oprolol hydrochlorotiazide; Mild to moderate hypertension

Indexed keywords

BISOPROLOL; HYDROCHLOROTHIAZIDE; METOPROLOL; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LONGITUDINAL STUDIES; MALE; METOPROLOL; MIDDLE AGED;

EID: 0034484062     PISSN: 00203785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Report of the Task Force on the availability cardiovascular drugs in the medically indigent
2. Systolic hypertension elderly program. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
3. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure
4. Blood pressure, stroke and coronary heart disease. Part 2, short-term reduction in blood pressure: Overview of randowized drug trials and their epidemiologic context
5. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the trials of hypertension prevention, phase I
6. National education program working group report on the management of patients with hypertension and high blood cholesterol
7. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris
8. Basic pharmacokinetics of bisoprolol, a new highly beta selective adrenoceptor antagonist
9. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorotiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension
10. Comparison of bisoprolol with atenolol for systemic hypertension in four groups (young, old, black and nonblack) using ambulatory blood pressure monitoring
11. Clinical use of beta adrenoceptor blockade in systemic hypertension
12. A comparison of bisoprolol and atenolol in treatment of mild to moderate hypertension
13. Quality of life perception during antihypertensive treatment: A comparative study of bisoprolol and enalapril
14. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry
15. Low-dose drug combination therapy: An alternative firts-line approach to hypertension treatment
16. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy
17. Efficacy of low dose combination of bisoprolol/hydrochlorotiazide compared with amlodipine and enalapril in men and women with essential hypertension
18. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorotiazide in patients with stage I and stage II systemic hypertension
19. Haemodynamic effects of bisoprolol in patients with coronary heart disease: Influence of various bisoprolol plasma concentrations
20. Coronary heart disease
21. Double-blind comparison of cardioselective betablockers bisoprolol and atenolol in hypertension: The bisoprolol international multicenter study (BIMS)
22. A comparison of the effects of bisoprolol and atenolol on lipoprotein concentrations and blood pressure
23. The evolution of antihypertensive therapy: An overview of four decades of experience